200 related articles for article (PubMed ID: 10226782)
1. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts.
Samuel DS; Ewton DZ; Coolican SA; Petley TD; McWade FJ; Florini JR
Horm Metab Res; 1999; 31(2-3):55-64. PubMed ID: 10226782
[TBL] [Abstract][Full Text] [Related]
2. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.
Coolican SA; Samuel DS; Ewton DZ; McWade FJ; Florini JR
J Biol Chem; 1997 Mar; 272(10):6653-62. PubMed ID: 9045696
[TBL] [Abstract][Full Text] [Related]
3. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
Haugk KL; Wilson HM; Swisshelm K; Quinn LS
Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
[TBL] [Abstract][Full Text] [Related]
6. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
Quinn LS; Anderson BG; Plymate SR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
Jones NC; Fedorov YV; Rosenthal RS; Olwin BB
J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation.
Sarbassov DD; Peterson CA
Mol Endocrinol; 1998 Dec; 12(12):1870-8. PubMed ID: 9849961
[TBL] [Abstract][Full Text] [Related]
9. Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism.
Winter B; Arnold HH
J Cell Sci; 2000 Dec; 113 Pt 23():4211-20. PubMed ID: 11069766
[TBL] [Abstract][Full Text] [Related]
10. IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways.
Kuemmerle JF; Bushman TL
Am J Physiol; 1998 Jul; 275(1):G151-8. PubMed ID: 9655695
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone and the insulin-like growth factor system in myogenesis.
Florini JR; Ewton DZ; Coolican SA
Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells.
Reusch HP; Zimmermann S; Schaefer M; Paul M; Moelling K
J Biol Chem; 2001 Sep; 276(36):33630-7. PubMed ID: 11443134
[TBL] [Abstract][Full Text] [Related]
13. Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation.
Adi S; Bin-Abbas B; Wu NY; Rosenthal SM
Endocrinology; 2002 Feb; 143(2):511-6. PubMed ID: 11796505
[TBL] [Abstract][Full Text] [Related]
14. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha.
Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE
Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516
[TBL] [Abstract][Full Text] [Related]
15. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.
Rommel C; Clarke BA; Zimmermann S; Nuñez L; Rossman R; Reid K; Moelling K; Yancopoulos GD; Glass DJ
Science; 1999 Nov; 286(5445):1738-41. PubMed ID: 10576741
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways.
Milasincic DJ; Calera MR; Farmer SR; Pilch PF
Mol Cell Biol; 1996 Nov; 16(11):5964-73. PubMed ID: 8887626
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1.
Samuels ML; McMahon M
Mol Cell Biol; 1994 Dec; 14(12):7855-66. PubMed ID: 7969125
[TBL] [Abstract][Full Text] [Related]
18. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.
Zhang D; Bar-Eli M; Meloche S; Brodt P
J Biol Chem; 2004 May; 279(19):19683-90. PubMed ID: 14993222
[TBL] [Abstract][Full Text] [Related]
19. Activated Raf-1 causes growth arrest in human small cell lung cancer cells.
Ravi RK; Weber E; McMahon M; Williams JR; Baylin S; Mal A; Harter ML; Dillehay LE; Claudio PP; Giordano A; Nelkin BD; Mabry M
J Clin Invest; 1998 Jan; 101(1):153-9. PubMed ID: 9421477
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2.
Weyman CM; Wolfman A
Endocrinology; 1998 Apr; 139(4):1794-800. PubMed ID: 9528964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
